Literature DB >> 31345830

West Nile encephalitis mimicking neuropsychiatric lupus in a patient with systemic lupus erythematosus.

Neena R Iyer1, W Joseph McCune2, Beth I Wallace2,3.   

Abstract

A man in his 70s with known systemic lupus erythematosus (SLE) was admitted with confusion, worsening proteinuria and cutaneous vasculitis despite adherence to his home immunosuppressive regimen. Admission laboratories were consistent with active lupus. Despite treatment with pulse-dose glucocorticoids and intravenous immunoglobulin, he developed worsening mental status and meningeal signs. Investigations revealed cerebrospinal fluid (CSF) neutrophilic and plasmacytic pleocytosis and negative cultures. Empiric treatment for SLE flare with potential neuropsychiatric involvement was continued while workup for altered mental status was ongoing. Ultimately, West Nile encephalitis was diagnosed by CSF serologies, and steroids were tapered. Altered mental status in a patient with SLE has a broad differential, and primary neuropsychiatric SLE should be considered only after exclusion of secondary causes. Although evidence of end-organ SLE activity usually lends support to a neuropsychiatric SLE diagnosis, in this case, serological and clinical evidence of SLE activity may have been triggered by acute viral infection. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  immunology; infectious diseases; systemic lupus erythematosus

Mesh:

Substances:

Year:  2019        PMID: 31345830      PMCID: PMC6663245          DOI: 10.1136/bcr-2019-229537

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis.

Authors:  Ruchi Srivastava; Chandran Ramakrishna; Edouard Cantin
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

2.  Complement activation is required for induction of a protective antibody response against West Nile virus infection.

Authors:  Erin Mehlhop; Kevin Whitby; Theodore Oliphant; Anantha Marri; Michael Engle; Michael S Diamond
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity.

Authors:  S Hirohata; S Hirose; T Miyamoto
Journal:  Arch Intern Med       Date:  1985-10

4.  Cerebrospinal fluid neutrophilic pleocytosis in hospitalized West Nile virus patients.

Authors:  Renee Crichlow; Jessica Bailey; Cameron Gardner
Journal:  J Am Board Fam Pract       Date:  2004 Nov-Dec

Review 5.  Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus.

Authors:  Virginia Fernandes Moça Trevisani; Aldemar A Castro; João Ferreira Neves Neto; Alvaro N Atallah
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

6.  Cerebrospinal fluid cytology in seasonal epidemic West Nile virus meningo-encephalitis.

Authors:  Ajay Rawal; Patrick J Gavin; Charles D Sturgis
Journal:  Diagn Cytopathol       Date:  2006-02       Impact factor: 1.582

7.  Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests.

Authors:  S G West; W Emlen; M H Wener; B L Kotzin
Journal:  Am J Med       Date:  1995-08       Impact factor: 4.965

8.  Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Authors:  John G Hanly; Li Su; Murray B Urowitz; Juanita Romero-Diaz; Caroline Gordon; Sang-Cheol Bae; Sasha Bernatsky; Ann E Clarke; Daniel J Wallace; Joan T Merrill; David A Isenberg; Anisur Rahman; Ellen M Ginzler; Michelle Petri; Ian N Bruce; M A Dooley; Paul Fortin; Dafna D Gladman; Jorge Sanchez-Guerrero; Kristjan Steinsson; Rosalind Ramsey-Goldman; Munther A Khamashta; Cynthia Aranow; Graciela S Alarcón; Barri J Fessler; Susan Manzi; Ola Nived; Gunnar K Sturfelt; Asad A Zoma; Ronald F van Vollenhoven; Manuel Ramos-Casals; Guillermo Ruiz-Irastorza; S Sam Lim; Kenneth C Kalunian; Murat Inanc; Diane L Kamen; Christine A Peschken; Soren Jacobsen; Anca Askanase; Chris Theriault; Kara Thompson; Vernon Farewell
Journal:  Arthritis Rheumatol       Date:  2015-07       Impact factor: 10.995

9.  The clinical response of West Nile virus neuroinvasive disease to intravenous immunoglobulin therapy.

Authors:  Zvi Shimoni; Hanna Bin; Shlomo Bulvik; Mark Niven; Rawi Hazzan; Ella Mendelson; Paul Froom
Journal:  Clin Pract       Date:  2012-01-27

10.  Risk of adverse events from different drugs for SLE: a systematic review and network meta-analysis.

Authors:  Jingru Tian; Yien Luo; Haijing Wu; Hai Long; Ming Zhao; Qianjin Lu
Journal:  Lupus Sci Med       Date:  2018-03-09
View more
  2 in total

Review 1.  Management of West Nile Encephalitis: An Uncommon Complication of West Nile Virus.

Authors:  Ammar Alli; Juan Fernando Ortiz; Adam Atoot; Ali Atoot; Paul W Millhouse
Journal:  Cureus       Date:  2021-02-06

Review 2.  Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions.

Authors:  Tao Ming Sim; Anselm Mak; Sen Hee Tay
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.